Emily Vertosick

Memorial Sloan Kettering Cancer Center

Papers

8

Total Citations

206

H-Index

5

About

Emily Vertosick is a leading biostatistician and researcher whose work has fundamentally shaped our understanding of surgical quality and outcomes in urologic oncology. Her primary research areas include the surgical learning curve, perioperative safety, and the optimization of functional outcomes following complex robotic procedures. Vertosick’s landmark study on the learning curve for robot-assisted radical prostatectomy (96 citations) provided critical evidence that surgeon experience directly impacts cancer control, quantifying the volume needed to reduce positive surgical margins. She has also made significant contributions to renal surgery, comparing retroperitoneal and transperitoneal approaches for partial nephrectomy while adjusting for tumor complexity. Her work extends to patient safety, notably assessing the risks of ambulatory cancer surgery for patients with obstructive sleep apnea. More recently, Vertosick has pioneered automated, longitudinal surgical evaluation systems to standardize training and feedback. Her rigorous methodological approach—leveraging large datasets and advanced statistical modeling—has produced actionable insights that directly improve patient care and surgical education at high-volume centers.

Research Focus

Key Achievements

5
H-Index
8
Papers
206
Total Citations
26
Avg Citations/Paper
🏆 Most Cited Paper
The Impact of Experience on the Risk of Surgical Margins and Biochemical Recurrence after Robot-Assisted Radical Prostatectomy: A Learning Curve Study
96 citations · 2019
📈 Most Prolific Year: 2019 (2 Papers)
🤝 Key Collaborators: 53
🏛 Institutions: Memorial Sloan Kettering Cancer Center

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago